Associated Papers
APOBEC3A Catalytic Inactivity Mutation Induces Tertiary Structure Destabilization.
Jones KFM et al.
Acs Medicinal Chemistry Letters, 2023
Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome.
Nakata Y et al.
Nucleic Acids Research, 2023
36610792 (PubMed )
Supplement: gkac1238_supplemental_file.pdf
Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.
Tang G et al.
Acs Synthetic Biology, 2021
APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.
Ziegler SJ et al.
Biochemistry, 2019
The DNA damage induced by the Cytosine Deaminase APOBEC3A Leads to the production of ROS.
Niocel M et al.
Scientific Reports, 2019
Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA et al.
Journal of Virology, 2018
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.
Bohn MF et al.
Structure (london, England : 1993), 2015
Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity.
Horn AV et al.
Nucleic Acids Research, 2014
Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.
Mitra M et al.
Nucleic Acids Research, 2014
Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.
Thielen BK et al.
The Journal of Biological Chemistry, 2010
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
Narvaiza I et al.
Plos Pathogens, 2009
Select a paper to view details